Guy Rosalia Van Lommen

This inventor holds 23 USPTO granted patents, primarily in Vasoconstrictive Compounds. Top assignees: Janssen Pharmaceutica Nv, Ciba-Geigy Corporation. Active years: 1987-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guy Rosalia Van Lommen. Retrieved from https://idiyas.com/inventor/guy-rosalia-van-lommen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 200(Granted Patents)

Company Filing History:

23 out of 2,101

Janssen Pharmaceutica Nv

patents

1 out of 6,858

Ciba-Geigy Corporation

patents

where one patent can have more than one assignee

Years Active: 1987-2000

Loading Chart...

Areas of Expertise:

Dopamine D4 Receptor Antagonist

Dihydrobenzopyran Derivatives

Substituted Aryloxyalkyl Diamines

Herbicidal Imidazoles

1H-Imidazole-5-Carboxylic Acid Derivatives

Spiro Compounds

Vasoconstrictive Substituted Compounds

2,4-Diaminopyrimidine Derivatives

Tricyclic Derivatives

Weed Control Methods

Polycyclic Substituted Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6159982 - 2,4-diaminopyrimidine derivates as dopamine D4 receptor antagonist (2000-12-12),

2. 6100268 - Vasoconstrictive dihydrobenzopyran derivatives (2000-08-08),

3. 5990123 - Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines (1999-11-23),

4. 5824682 - Vasoconstrictive dihydrobenzopyran derivatives (1998-10-20),

5. 5801179 - Vasoconstrictive substituted aryloxyalkyl diamines (1998-09-01),

6. 5703115 - �(benzodioxan, benzofuran or benzopyran) alkylamino! alkyl substituted (1997-12-30),

7. 5691344 - Vasoconstrictive substituted dihydropyranopyridines (1997-11-25),

8. 5688952 - �(Benzodioxan benzofuran or benzopyran) alkylamino!alkyl substituted (1997-11-18),

9. 5677310 - Vasoconstrictive substituted aryloxyalkyl diamines (1997-10-14),

10. 5624952 - [(Benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted (1997-04-29),

11. 5607949 - [(Benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted (1997-03-04),

12. 5541180 - [(benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted (1996-07-30),

13. 5369084 - Isonicotinic acid derivatives and related spiro compounds with (1994-11-29),

14. 5246915 - Method for controlling weeds (1993-09-21),

15. 4994103 - 1,5-substituted 1H-imidazoles (1991-02-19),

Title: Guy Rosalia Van Lommen: An Innovator in Pharmaceutical Patents

Introduction:

Guy Rosalia Van Lommen, based in Berlaar, Belgium, is a prominent inventor with a remarkable portfolio of 23 patents. His contributions, particularly in the pharmaceutical field, have positioned him as a notable figure in the industry.

Latest Patents:

Among his latest inventions are two significant patents that focus on novel compounds. The first is related to 2,4-diaminopyrimidine derivatives, which serve as dopamine D4 receptor antagonists. The second patent highlights vasoconstrictive dihydrobenzopyran derivatives. This invention details compounds characterized by specific structural formulas, providing various chemical functionalities that enhance their therapeutic potential. The pharmaceutically acceptable acid addition salts and their stereochemical isomeric forms broaden the application of his innovations in medicine.

Career Highlights:

Throughout his career, Van Lommen has been affiliated with leading companies like Janssen Pharmaceutica NV and Ciba-Geigy Corporation. His work in these esteemed organizations has contributed significantly to advancements in pharmacology and therapeutic development.

Collaborations:

Guy Rosalia Van Lommen has collaborated with notable colleagues, including Marcel F. De Bruyn and William R. Lutz. Their partnerships have likely fostered an environment of innovation, combining expertise to produce impactful inventions in the pharmaceutical domain.

Conclusion:

Guy Rosalia Van Lommen exemplifies the spirit of innovation within the pharmaceutical industry. With an impressive number of patents and impactful collaborations, his work continues to influence the development of new medical therapies, showcasing the significance of inventorship in making strides toward improved healthcare solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]